We are live on ! Find out more
MMPW

Mitchell McLeod Pugh & Williams Portfolio holdings

AUM $815M Turnover 10.9%
1-Year Est. Return 30.42%
This Fund
S&P 500
This Quarter Est. Return
+22.17%
1 Year Est. Return
+30.42%
3 Year Est. Return
+90.74%
5 Year Est. Return
+119.86%
10 Year Est. Return
+429.51%
AUM
$176M
AUM Growth
+$46.3M
Cap. Flow
+$20.8M
Cap. Flow %
11.84%
Top 10 Hldgs %
26.91%
Holding
190
New
24
Increased
90
Reduced
23
Closed
4
Avg Time Held
4.1 years
Top 10 Avg Time Held
2.2 years
Top 20 Avg Time Held
3 years

Top Sells

Rank Stock Value
1
AGN
Allergan Inc
AGN
+$705K
2
RTN
Raytheon Company
RTN
+$302K
3
WY icon
Weyerhaeuser
WY
+$238K
4
BIIB icon
Biogen
BIIB
+$207K
5
C icon
Citigroup
C
+$204K

Sector Composition

Rank Sector Weight
1 Technology 22.87%
2 Healthcare 13.03%
3 Financials 11.51%
4 Miscellaneous 10.09%
5 Consumer Discretionary 8.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
FMS icon
176
Fresenius Medical Care
FMS
$11.9B
$209K 0.12%
+4,830
New +$191K
2020 Q2
0 quarters
GSK icon
177
GSK
GSK
$99.3B
$203K 0.12%
+3,976
New +$204K
2020 Q2
0 quarters
OKTA icon
178
Okta
OKTA
$33.7B
$200K 0.11%
+1,000
New +$170K
2020 Q2
0 quarters
HPQ icon
179
HP
HPQ
$27.6B
$179K 0.1%
10,270
– –
2014 Q4
22 quarters
PRA icon
180
DELISTED
ProAssurance
PRA
$172K 0.1%
11,862
– –
2014 Q4
22 quarters
CCL icon
181
Carnival Corporation Ltd
CCL
$36B
$165K 0.09%
+10,030
New +$150K
2020 Q2
0 quarters
SIRI icon
182
SiriusXM
SIRI
$9.19B
$144K 0.08%
2,447
– –
2017 Q1
13 quarters
AMCR icon
183
DELISTED
AMCOR LTD ADR
AMCR
$124K 0.07%
12,096
-590
-5% -$6.05K
2019 Q2
4 quarters
AMRN icon
184
Amarin Corp
AMRN
$243M
$117K 0.07%
849
+286
+51% +$39.3K
2020 Q1
1 quarter
GRCE icon
185
Grace Therapeutics
GRCE
$40.2M
$21K 0.01%
938
– –
2019 Q3
3 quarters
BIIB icon
186
Biogen
BIIB
$34.6B
– –
-655
Closed -$207K –
WY icon
187
Weyerhaeuser
WY
$14.1B
– –
-14,069
Closed -$238K –
RTN
188
DELISTED
Raytheon Company
RTN
– –
-2,299
Closed -$302K –
AGN
189
DELISTED
Allergan Inc
AGN
– –
-3,982
Closed -$705K –

Similar funds

Mitchell McLeod Pugh & Williams's Q2 2020 Portfolio in Review

As of Q2 2020, Mitchell McLeod Pugh & Williams held 190 positions worth $176M, up 36% from $130M the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Mitchell McLeod Pugh & Williams deployed $20.8M of net new capital in Q2 2020, opening 24 new positions and adding to 90 existing holdings. Its largest new stake was Lockheed Martin: 2,072 shares worth $756K.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 21% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Citigroup, an estimated $204K trimmed.

  • Mitchell McLeod Pugh & Williams's largest Q2 2020 buy was Lockheed Martin: 2,072 shares worth $756K.
  • Mitchell McLeod Pugh & Williams added most to Vanguard Morningstar Growth ETF in Q2 2020, an estimated $2.07M increase.
  • Mitchell McLeod Pugh & Williams's biggest Q2 2020 reduction was Citigroup, cutting an estimated $204K.
  • Mitchell McLeod Pugh & Williams fully exited Allergan Inc in Q2 2020, selling an estimated $705K.
  • Mitchell McLeod Pugh & Williams's ten largest holdings make up 27% of its $176M portfolio in Q2 2020.
  • Mitchell McLeod Pugh & Williams opened 24 new positions and closed 4 in Q2 2020.
  • Mitchell McLeod Pugh & Williams's portfolio value rose 36% quarter-over-quarter to $176M.

Based on Mitchell McLeod Pugh & Williams's 13F filing for Q2 2020, filed 17 Jul 2020.